Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival.
Clauss A, Ng V, Liu J, Piao H, Russo M, Vena N, Sheng Q, Hirsch MS, Bonome T, Matulonis U, Ligon AH, Birrer MJ, Drapkin R
Neoplasia. 2010 Feb;12(2):161-72.
(Link opens in a new window)
PubMed
Plasmids from Article
ID | Plasmid | Purpose |
---|---|---|
18099 | pGEX-Elafin |